A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This surgical technique illustrates the injection of gene therapy vectors and stem cells into the subretinal space of the mouse eye.

Abstract

The loss of sight affects approximately 3.4 million people in the United States and is expected to increase in the upcoming years.1 Recently, gene therapy and stem cell transplantations have become key therapeutic tools for treating blindness resulting from retinal degenerative diseases. Several forms of autologous transplantation for age-related macular degeneration (AMD), such as iris pigment epithelial cell transplantation, have generated encouraging results, and human clinical trials have begun for other forms of gene and stem cell therapies.2 These include RPE65 gene replacement therapy in patients with Leber's congenital amaurosis and an RPE cell transplantation using human embryonic stem (ES) cells in Stargardt's disease.3-4 Now that there are gene therapy vectors and stem cells available for treating patients with retinal diseases, it is important to verify these potential therapies in animal models before applying them in human studies. The mouse has become an important scientific model for testing the therapeutic efficacy of gene therapy vectors and stem cell transplantation in the eye.5-8 In this video article, we present a technique to inject gene therapy vectors or stem cells into the subretinal space of the mouse eye while minimizing damage to the surrounding tissue.

Protocol

1. Assemble Devices for the Subretinal Injection

  1. Purchase or make a 100 μm diameter needle from a glass capillary tube. This can be done manually by using a Sutter P-97 pipet puller or other similar equipment. The end of the capillary tube will be heated and pulled until it reaches the desired diameter (100 μm). A smaller diameter needle can be used for gene therapy vectors; however, this is the recommended diameter for cell injection without damage to the cells or the eye. Compared to steel needles, the glass capillary needle has a very fine, but blunt tip, to allow for visualization of the injection fluid and access to the subretinal space without....

Results

A drawing of the mouse eye is shown with major structures labeled for reference, with arrows displaying the locations for both intravitreal and subretinal injection surgical procedures (arrowheads, Figure 1). Gene therapy vectors, such as the lacZ lentiviral vector (Figure 2), can be injected using these locations. Additionally, stem cells, such as mouse embryonic stem cells (Figure 3), can also be transplanted at these sites in the mouse eye.

Discussion

This video technique provides instructions on completing the subretinal injection surgical procedure successfully, and ensuring that the gene therapy vector or stem cells are placed in the location necessary to efficiently treat the ophthalmic disease. This technique allows for the targeting of retinal cells such as the RPE or photoreceptors, since it places the gene therapy vectors or stem cell-derived tissues in the vicinity of these cells. Previous methods involved intravitreal injections, where the fluid is placed wi.......

Disclosures

No conflicts of interest declared.

Acknowledgements

Research to Prevent Blindness; Experimental assistance from Takayuki Nagasaki; This research complies with the ARVO Statement for the Use of Animals in Ophthalmic and Visual Research. KJW is supported by NIH grants 5T32EY013933 and 5T32DK007647-20. VBM is supported by NIH grant K08EY020530.

....

Materials

NameCompanyCatalog NumberComments
NameCompanyCatalogComments
0.8-1.10 x 100 mm Capillary Tube (glass)Kimble Glass, Inc.34502 99
Flaming/Brown Micropipette Puller Sutter InstrumentP-97Narishige microforge can be used instead.  Catalog #MF-900
SigmacoteSigma AldrichSL2-25MLSilicone
Dubecco's Phosphate Buffered Saline with Calcium Chloride and Magnesium ChlorideGibco-Invitrogen14040-133
Safety-Lok 25 3/4G x 12"; Blood Collection SetB-D Vacutainer367298
1 ml Sub-Q 26 5/8G Slip-Tip SyringeBecton-Dickinson309597
0.5-10 μl Finnpipette II Adjustable-Volume PipetterFisherbrand21-377-815
1-200 μl Natural Beveled TipsUSA Scientific, Inc.1111-1700
Discovery.V8 Stereo MicroscopeZeissMC1500
60 mm x 15 mm Style Treated Polystyrene Cell Culture DishCorning Incorporated430166
Vannas Straight ScissorsStorz OphthalmicsE3383 S
Curved Dressing Forceps with Serrations DelicateStorz OphthalmicsE1408
15 Degree Microsurgery KnifeWilson Ophthalmic Corp.091204
KetamineKetaset IIINADA #45-290
XylazineLloyd LaboratoriesNADA #139-236
Bupivacaine (Marcaine)AstraZenecaN/A
Buprenorphine Sigma AldrichB9275

References

  1. Abe, T. Regeneration of the retina using pigment epithelial cell transplantation. Nihon Ganka Gakkai Zasshi. 106, 778-803 (2002).
  2. Jacobson, S. G., Cideciyan, A. V., Ratnakaram, R., Heon, E., Schwartz, S. B., Roman, A. J., Peden, M. C., Aleman, T. S., Boye, S. L., Sumaroka, A., et al.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Subretinal InjectionGene Therapy VectorsStem CellsPerinatal Mouse EyeBlindnessRetinal Degenerative DiseasesAutologous TransplantationAge related Macular Degeneration AMDIris Pigment Epithelial Cell TransplantationRPE65 Gene Replacement TherapyLeber s Congenital AmaurosisRPE Cell TransplantationStargardt s DiseaseAnimal ModelsTherapeutic EfficacyEye Tissue Preservation

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved